{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:37:20Z","timestamp":1783676240132,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejvs.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T03:17:13Z","timestamp":1371266233000},"page":"201-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Incidence and the Clinical Impact of Stent Fractures after Primary Stenting for TASC C and D Femoropopliteal Lesions at 1 Year"],"prefix":"10.1016","volume":"46","author":[{"given":"J.M.","family":"Davaine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Qu\u00e9rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guyomarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u00c1.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Costargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chaillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gou\u00ebffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2013.05.010_bib1","doi-asserted-by":"crossref","unstructured":"Acin F, de Haro J, Bleda S, Varela C, Esparza L. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther;19:585\u201395.","DOI":"10.1583\/JEVT-12-3898R.1"},{"key":"10.1016\/j.ejvs.2013.05.010_bib2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2013.05.010_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejvs.2008.05.005","article-title":"The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings","volume":"36","author":"Rits","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2013.05.010_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2013.05.010_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2013.05.010_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jvs.2011.03.272","article-title":"One-year results with the Protege EverFlex 200-mm-long nitinol stent (ev3) in TransAtlantic Inter-Society Consensus C and D femoropopliteal lesions: durability-200 study","volume":"54","author":"Bosiers","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2013.05.010_bib7","doi-asserted-by":"crossref","unstructured":"Davaine JM, Azema L, Guyomarch B, Chaillou P, Costargent A, Patra P, et\u00a0al. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA \u201cSTEnting Long de L'Artere femorale superficielle\u201d cohort). Eur J Vasc Endovasc Surg;44:432\u201341.","DOI":"10.1016\/j.ejvs.2012.07.015"},{"key":"10.1016\/j.ejvs.2013.05.010_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.99.1.44","article-title":"Pathology of acute and chronic coronary stenting in humans","volume":"99","author":"Farb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2013.05.010_bib9","unstructured":"Hanna EB. Dual antiplatelet therapy in peripheral arterial disease and after peripheral percutaneous revascularization. J Invasive Cardiol;24:679\u201384."},{"key":"10.1016\/j.ejvs.2013.05.010_bib10","first-page":"460","article-title":"Standardized evaluation and reporting of stent fractures in clinical trials of\u00a0noncoronary devices","volume":"70","author":"Jaff","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2013.05.010_bib11","first-page":"22","article-title":"Nitinol stent fractures in the SFA","volume":"3","author":"Allie","year":"2004","journal-title":"Endovasc Today"},{"key":"10.1016\/j.ejvs.2013.05.010_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejvs.2008.06.020","article-title":"Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions","volume":"36","author":"Diehm","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2013.05.010_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/eurheartj\/ehl545","article-title":"A\u00a0call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries","volume":"28","author":"Diehm","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2013.05.010_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10\u00a0cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2013.05.010_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","article-title":"Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results","volume":"106","author":"Duda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2013.05.010_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.amjcard.2008.12.022","article-title":"A\u00a0qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation","volume":"103","author":"Popma","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2013.05.010_bib17","doi-asserted-by":"crossref","unstructured":"Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et\u00a0al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv;3:267\u201376.","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"10.1016\/j.ejvs.2013.05.010_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1583\/08-2676.1","article-title":"Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study","volume":"16","author":"Bosiers","year":"2009","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2013.05.010_bib19","doi-asserted-by":"crossref","unstructured":"Iida O, Uematsu M, Soga Y, Hirano K, Suzuki K, Yokoi H, et\u00a0al. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv;78:611\u20137.","DOI":"10.1002\/ccd.23064"},{"key":"10.1016\/j.ejvs.2013.05.010_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1583\/05-1672.1","article-title":"Long-segment SFA stenting \u2013 the dark sides: in-stent restenosis, clinical deterioration, and stent fractures","volume":"12","author":"Schlager","year":"2005","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2013.05.010_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jvs.2008.02.029","article-title":"Fracture of self-expanding nitinol stents stressed in\u00a0vitro under simulated intravascular conditions","volume":"48","author":"Nikanorov","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2013.05.010_bib22","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2013.05.010_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1583\/04-1359.1","article-title":"Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries","volume":"12","author":"Sabeti","year":"2005","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2013.05.010_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.amjcard.2006.01.091","article-title":"Effect of exercise on frequency of stent fracture in the superficial femoral artery","volume":"98","author":"Iida","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2013.05.010_bib25","doi-asserted-by":"crossref","unstructured":"Damelou A, Davlouros PA, Alexopoulos D. Late asymptomatic sirolimus-eluting stent fracture in a female with systemic lupus erythematosus. Int J Cardiol;149:e72\u20134.","DOI":"10.1016\/j.ijcard.2009.03.116"},{"key":"10.1016\/j.ejvs.2013.05.010_bib26","doi-asserted-by":"crossref","unstructured":"Davlouros PA, Nikokiris G, Karantalis V, Mavronasiou E, Xanthopoulou I, Damelou A, et\u00a0al. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study. Int J Cardiol;151:155\u20139.","DOI":"10.1016\/j.ijcard.2010.05.004"},{"key":"10.1016\/j.ejvs.2013.05.010_bib27","doi-asserted-by":"crossref","unstructured":"Okamura T, Matsuzaki M. Sirolimus-eluting stent fracture detection by three-dimensional optical coherence tomography. Catheter Cardiovasc Interv;79:628\u201332.","DOI":"10.1002\/ccd.23268"},{"key":"10.1016\/j.ejvs.2013.05.010_bib28","doi-asserted-by":"crossref","unstructured":"Lensvelt MM, Holewijn S, Fritschy WM, Wikkeling OR, van Walraven LA, Wallis de Vries BM, et\u00a0al. SUrgical versus PERcutaneous Bypass: SUPERB-trial; heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial. Trials;12:178.","DOI":"10.1186\/1745-6215-12-178"},{"key":"10.1016\/j.ejvs.2013.05.010_bib29","doi-asserted-by":"crossref","unstructured":"McQuade K, Gable D, Pearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE\/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg;52:584\u201390. [discussion 590\u20131, 591e1\u20137].","DOI":"10.1016\/j.jvs.2010.03.071"},{"key":"10.1016\/j.ejvs.2013.05.010_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCINTERVENTIONS.108.789974","article-title":"Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation","volume":"1","author":"Schwartz","year":"2008","journal-title":"Circ Cardiovasc Interv"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588413003304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588413003304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:25Z","timestamp":1761046765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588413003304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1078588413003304"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2013.05.010","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and the Clinical Impact of Stent Fractures after Primary Stenting for TASC C and D Femoropopliteal Lesions at 1 Year","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}